text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070847/2022

text: clinical

text: Baseline surveillance


status: PUBLIC

text: SARS-CoV-2: clinical or host-associated

tag: attribute

characteristic: BioSampleModel

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: pda|emily.smith@theiagen.com

characteristic: INSDC center alias

text: pda|emily.smith@theiagen.com

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: NCBI

characteristic: broker name

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

characteristic: host

text: SARS-CoV-2/Human/USA/CA-CDPH-500070848/2022

characteristic: isolate

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

characteristic: organism

text: Baseline surveillance

characteristic: title


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070850/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070851/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070852/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070853/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070854/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070855/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070856/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070857/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070858/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070860/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070861/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070862/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070864/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070865/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070866/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070867/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070869/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070870/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070871/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070872/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070873/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070876/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070877/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070878/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070879/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070880/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070882/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070883/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070884/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070885/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070886/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070887/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070888/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070889/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070890/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070891/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070892/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070893/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070894/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070897/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070898/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070899/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070900/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070901/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070902/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070903/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070904/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070905/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070906/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070907/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070908/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070909/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070910/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070911/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070912/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070913/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070915/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070916/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070917/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070918/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070920/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070921/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070922/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070924/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070925/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070926/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070929/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070930/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070931/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070932/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070935/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070936/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070937/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070938/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070939/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070940/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070943/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070944/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070945/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070946/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070948/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070950/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070951/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070952/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070954/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070955/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070956/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070957/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070958/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070960/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070961/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070962/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070963/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070965/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070967/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070968/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070969/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070971/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070972/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070973/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070974/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070975/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070976/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070977/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070978/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070979/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070980/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070981/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: TPMG Regional Laboratory

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-500070983/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002086/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002125/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002165/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002348/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002485/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002509/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002597/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002735/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002849/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002888/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002894/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002903/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002908/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002910/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002911/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002914/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002918/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002919/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002926/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002938/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002940/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002951/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002959/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002963/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002968/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002970/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002971/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002975/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002984/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002985/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002987/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002990/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002991/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002997/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002998/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000002999/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003000/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003001/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003006/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003007/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003008/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003010/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003011/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003012/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003027/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003032/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003035/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003036/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003046/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003058/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003065/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003074/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003078/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003092/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003094/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003097/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003102/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003108/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003118/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003119/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003121/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003123/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003125/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003130/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003134/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003145/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003146/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003152/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003155/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003158/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003164/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003165/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003174/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003176/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003182/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003184/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003192/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003197/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003198/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003199/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003203/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003213/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003216/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003221/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003227/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003228/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003238/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003239/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003240/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003242/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003243/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003244/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003247/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003251/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003256/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003261/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: School Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-8000003270/2022

text: clinical

text: Targetted sequencing


text: SARS-CoV-2: clinical or host-associated

text: unh-hcgs

text: unh-hcgs

text: public

text: NCBI

text: University of New Hampshire

text: swab

text: USA: New Hampshire

text: Homo sapiens

text: female

text: anterior nares

text: SARS-CoV-2: clinical or host-associated sample from Severe acute respiratory syndrome coronavirus 2


text: University of houston

characteristic: INSDC secondary accession

text: live

text: Plant

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: age

text: Omani

characteristic: cultivar

text: Adult

text: Oman

text: sacra

text: Boswellia

text: Root

characteristic: tissue

text: Plant sample from Boswellia


characteristic: External Id

text: University of California

characteristic: INSDC center name

text: live

text: Microbe, viral or environmental

text: USA: California

text: potato

text: Phytophthora infestans

text: hyphae from F1 progeny

characteristic: strain

text: Microbe sample from Phytophthora infestans


name: C. elegans (BK36) - FAC sorted  Large GFP+

text: Invertebrate

characteristic: BioSampleModel

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: INSDC center alias

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: NCBI

text: USA

text: CGC

text: Caenorhabditis elegans

text: BK36 large GFP-tagged cells

text: Caenorhabditis elegans


name: C. elegans (BK36) - FAC sorted Small GFP+

text: Invertebrate

text: public

characteristic: SRA accession

characteristic: Submitter Id

text: NCBI

characteristic: broker name

text: USA

characteristic: isolate

text: CGC

text: Caenorhabditis elegans

characteristic: organism

text: BK36 small GFP-tagged cells

text: Caenorhabditis elegans

characteristic: title


C. elegans (BK36) - FAC sorted GFP-

text: Invertebrate

text: public

text: C. elegans (BK36) - FAC sorted GFP-

text: NCBI

text: USA

text: CGC

text: Caenorhabditis elegans

text: Untagged cells

characteristic: tissue

text: Caenorhabditis elegans


name: B. malayi mf FAC sorted: Round cells (+) Wolb. (MA1)

text: Invertebrate

characteristic: External Id

text: public

text: NCBI

text: USA

text: Homo sapiens

characteristic: host

text: Brugia malayi

text: Round cells (+) Wolb.

text: Brugia malayi


name: B. malayi mf FAC sorted: High SSC +/- Wolb. (MA2)

text: Invertebrate

characteristic: INSDC center name

text: public

text: NCBI

text: USA

text: Homo sapiens

text: Brugia malayi

text: High SSC +/- Wolb.

text: Brugia malayi


name: B. malayi mf FAC sorted: High FSC +/- Wolb. (MA3)

text: Invertebrate

characteristic: BioSampleModel

text: public

text: NCBI

text: USA

text: Homo sapiens

text: Brugia malayi

text: High FSC +/- Wolb.

text: Brugia malayi


name: B. malayi mf FAC sorted: Round cells (-) Wolb. (MA4)

text: Invertebrate

characteristic: ENA-FIRST-PUBLIC

text: public

text: NCBI

text: USA

text: Homo sapiens

text: Brugia malayi

text: Round cells (-) Wolb.

text: Brugia malayi


name: B. malayi mf FAC sorted: Highest SSC +/- Wolb. (MA5)

text: Invertebrate

characteristic: ENA-LAST-UPDATE

text: public

text: NCBI

text: USA

text: Homo sapiens

text: Brugia malayi

text: Highest SSC +/- Wolb.

text: Brugia malayi


name: B. malayi mf FAC sorted: Highest FSC +/- Wolb. (MA6)

text: Invertebrate

characteristic: INSDC center alias

text: public

text: NCBI

text: USA

text: Homo sapiens

text: Brugia malayi

text: Highest FSC +/- Wolb.

text: Brugia malayi


text: Metagenome or environmental

characteristic: INSDC first public

text: public

characteristic: aliquot

text: NCBI

text: China: Glacier No. 1 at Headwaters of Urumqi River, Tianshan Mountains

text: the sueface snow

text: 43.10 N 86.82 E

text: glacier metagenome

text: glacier metagenome


text: Zhejiang University

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: MIGS.ba

characteristic: NCBI submission model

text: MIGS/MIMS/MIMARKS.plant-associated

characteristic: NCBI submission package

text: Keywords: GSC:MIxS;MIGS:5.0

characteristic: description

text: shake-flask culture

text: China: Hangzhou

text: Spanish melon

text: 30℃ biological replicate 1

text: 30.295381 N 120.082144 E

text: Sphingomonas melonis

text: GenBank GCA_001761345.1

text: Sphingomonas melonis TY

characteristic: strain


text: Zhejiang University

text: live

text: MIGS.ba

text: MIGS/MIMS/MIMARKS.plant-associated

characteristic: SRA accession

text: Keywords: GSC:MIxS;MIGS:5.0

text: shake-flask culture

text: China: Hangzhou

text: Spanish melon

text: 30℃ biological replicate 2

text: 30.295381 N 120.082144 E

text: Sphingomonas melonis

characteristic: organism

text: GenBank GCA_001761345.1

text: Sphingomonas melonis TY

characteristic: title


characteristic: External Id

text: Zhejiang University

characteristic: INSDC center name

text: live

text: MIGS.ba

text: MIGS/MIMS/MIMARKS.plant-associated

text: Keywords: GSC:MIxS;MIGS:5.0

text: shake-flask culture

text: China: Hangzhou

text: Spanish melon

characteristic: host

text: 30℃ biological replicate 3

text: 30.295381 N 120.082144 E

text: Sphingomonas melonis

text: GenBank GCA_001761345.1

text: Sphingomonas melonis TY


Mouse RAW264.7 seq sample-001

text: Soochow University

text: live

text: Model organism or animal

text: mature mouse

text: Abelson mouse leukaemia cancer tissue

characteristic: isolate

text: Mus musculus

text: male

characteristic: sex

text: mouse RAW264.7 cell line

text: cancer

characteristic: tissue

text: Model organism or animal sample from Mus musculus


text: State Hygienic Laboratory at the University of Iowa

characteristic: INSDC first public

text: live

text: SARS-CoV-2: clinical or host-associated

text: University of Iowa Hospitals and Clinics

text: USA: Iowa

text: Homo sapiens

text: clinical

text: Baseline surveillance


characteristic: INSDC last update

text: live

text: SARS-CoV-2: clinical or host-associated

text: USA: Iowa

text: Homo sapiens

text: clinical

text: Baseline surveillance


tag: Namespace:ICER Cambodia

text: ICER Cambodia

characteristic: INSDC secondary accession

text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIMS.me

text: Febrile illness study

text: Febrile illness study

text: city ENVO:00001020

text: Cambodia:Kampong Speu

text: Homo sapiens

text: fever DOID:11100

text: Zymo Pathogen Magbead

text: 11.4650 N 104.5073 E

text: human blood metagenome

text: sera

text: Illumina NovaSeq

text: viral fraction RNA metagenome (RNA virome)


text: ICER Cambodia

text: live

characteristic: INSDC status

text: MIGS/MIMS/MIMARKS.human-associated

text: MIMS.me

text: Febrile illness study

text: Febrile illness study

text: city ENVO:00001020

text: Cambodia:Kampong Speu

text: Homo sapiens

text: fever DOID:11100

text: Zymo Pathogen Magbead

text: 11.4650 N 104.5073 E

text: human blood metagenome

text: sera

text: Illumina NovaSeq


text: Tianjin University of Traditional Chinese Medicine

text: live

text: MIMAG.plant-associated

characteristic: NCBI submission model

text: Keywords: GSC:MIxS;MIMAG:5.0

text: mountain

text: mountain

text: fresh leaves

text: China: Gansu

text: Stems and branches with densely gray or grayish yellow silky pilose

text: gansu

text: 34.69 N 105.76 E

text: Artemisia capillaris

text: MIMAG Metagenome-assembled Genome sample from Artemisia capillaris


text: Southwest University

text: live

text: Plant

characteristic: NCBI submission package

text: 8 year

characteristic: age

text: China: Chongqing

text: Thuja sutchuenensis

text: young needles

text: Plant sample from Thuja sutchuenensis


text: Northwest A & F University

text: live

text: Metagenome or environmental

text: Panicum miliaceum L.

text: reator sample

text: soil metagenome


GAPDH trigger seq with sensor repl 1

text: Stanford University

text: live

text: Human

text: GAPDH trigger

characteristic: amplicon target

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: GAPDH trigger sequencing (SI Fig 2k)

characteristic: description

text: Homo sapiens

characteristic: replicate

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

text: 450 ng GAPDH.s1 + 50 ng ADAR1-p150

characteristic: treatment


GAPDH trigger seq with sensor repl 2

characteristic: External Id

text: Stanford University

text: live

text: Human

characteristic: SRA accession

text: GAPDH trigger

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: GAPDH trigger sequencing (SI Fig 2k)

text: Homo sapiens

characteristic: organism

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

characteristic: title

text: 450 ng GAPDH.s1 + 50 ng ADAR1-p150


GAPDH trigger seq with sensor repl 3

text: Stanford University

characteristic: INSDC center name

text: live

text: Human

text: GAPDH trigger

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: GAPDH trigger sequencing (SI Fig 2k)

characteristic: isolate

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

characteristic: sex

text: embryonic kidney

text: 450 ng GAPDH.s1 + 50 ng ADAR1-p150


GAPDH trigger seq without sensor repl 1

text: Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: GAPDH trigger

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: GAPDH trigger sequencing (SI Fig 2k)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

characteristic: tissue

text: 450 ng s70587 + 50 ng ADAR1-p150


GAPDH trigger seq without sensor repl 2

text: Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

text: GAPDH trigger

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: GAPDH trigger sequencing (SI Fig 2k)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

text: 450 ng s70587 + 50 ng ADAR1-p150


GAPDH trigger seq without sensor repl 3

text: Stanford University

text: live

text: Human

characteristic: NCBI submission package

characteristic: age

text: GAPDH trigger

characteristic: amplicon target

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: GAPDH trigger sequencing (SI Fig 2k)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

text: 450 ng s70587 + 50 ng ADAR1-p150


GAPDH sensor seq without siRNA repl 1

text: Stanford University

text: live

text: Human

text: GAPDH sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: GAPDH sensor sequencing (SI Fig 2h)

characteristic: description

text: Homo sapiens

characteristic: replicate

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

text: 450 ng GAPDH.s1 + 50 ng ADAR1-p150 + 100 nM PPIB siRNA + 0 nM GAPDH siRNA

characteristic: treatment


GAPDH sensor seq with siRNA repl 1

characteristic: External Id

text: Stanford University

text: live

text: Human

characteristic: SRA accession

text: GAPDH sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: GAPDH sensor sequencing (SI Fig 2h)

text: Homo sapiens

characteristic: organism

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

text: 450 ng GAPDH.s1 + 50 ng ADAR1-p150 + 0 nM PPIB siRNA + 100 nM GAPDH siRNA


GAPDH sensor seq without siRNA repl 2

text: Stanford University

characteristic: INSDC center name

text: live

text: Human

text: GAPDH sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: GAPDH sensor sequencing (SI Fig 2h)

characteristic: isolate

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

characteristic: title


GAPDH sensor seq with siRNA repl 2

text: Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: GAPDH sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: GAPDH sensor sequencing (SI Fig 2h)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

characteristic: sex

text: embryonic kidney


GAPDH sensor seq without siRNA repl 3

text: Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: GAPDH sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: GAPDH sensor sequencing (SI Fig 2h)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

characteristic: tissue


GAPDH sensor seq with siRNA repl 3

text: Stanford University

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: age

text: GAPDH sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: GAPDH sensor sequencing (SI Fig 2h)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney


name: DNAJB1 sensor sequencing with control siRNA repl 1

text: Stanford University

text: live

text: Human

text: DNAJB1 sensor

characteristic: amplicon target

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: DNAJB1 sensor sequencing (SI Fig 2i)

characteristic: description

text: Homo sapiens

characteristic: replicate

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

text: 450 ng DNAJB1.s1 + 50 ng ADAR1-p150 + VCL siRNA


name: DNAJB1 sensor sequencing with siRNA repl 1

characteristic: External Id

text: Stanford University

text: live

text: Human

characteristic: SRA accession

text: DNAJB1 sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: DNAJB1 sensor sequencing (SI Fig 2i)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

text: 450 ng DNAJB1.s1 + 50 ng ADAR1-p150 + DNAJB1 siRNA

characteristic: treatment


name: DNAJB1 sensor sequencing with control siRNA repl 2

text: Stanford University

characteristic: INSDC center name

text: live

text: Human

text: DNAJB1 sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: DNAJB1 sensor sequencing (SI Fig 2i)

characteristic: isolate

text: Homo sapiens

characteristic: organism

text: cell culture cDNA amplicon

text: female

text: embryonic kidney


name: DNAJB1 sensor sequencing with siRNA repl 2

text: Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: DNAJB1 sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: DNAJB1 sensor sequencing (SI Fig 2i)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

characteristic: title


name: DNAJB1 sensor sequencing with control siRNA repl 3

text: Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: DNAJB1 sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: DNAJB1 sensor sequencing (SI Fig 2i)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

characteristic: sex

text: embryonic kidney


name: DNAJB1 sensor sequencing with siRNA repl 3

text: Stanford University

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: DNAJB1 sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: DNAJB1 sensor sequencing (SI Fig 2i)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

characteristic: tissue


name: DNAJB1 sensor sequencing with control siRNA and heat shock repl 1

text: Stanford University

text: live

text: Human

characteristic: age

text: DNAJB1 sensor

characteristic: amplicon target

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: DNAJB1 sensor sequencing (SI Fig 2i)

characteristic: description

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

text: 450 ng DNAJB1.s1 + 50 ng ADAR1-p150 + VCL siRNA + heat shock


name: DNAJB1 sensor sequencing with siRNA and heat shock repl 1

characteristic: External Id

text: Stanford University

text: live

text: Human

characteristic: SRA accession

text: DNAJB1 sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: DNAJB1 sensor sequencing (SI Fig 2i)

text: Homo sapiens

characteristic: replicate

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

text: 450 ng DNAJB1.s1 + 50 ng ADAR1-p150 + DNAJB1 siRNA + heat shock


name: DNAJB1 sensor sequencing with control siRNA and heat shock repl 2

text: Stanford University

characteristic: INSDC center name

text: live

text: Human

text: DNAJB1 sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: DNAJB1 sensor sequencing (SI Fig 2i)

characteristic: isolate

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

characteristic: treatment


name: DNAJB1 sensor sequencing with siRNA and heat shock repl 2

text: Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: DNAJB1 sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: DNAJB1 sensor sequencing (SI Fig 2i)

text: Homo sapiens

characteristic: organism

text: cell culture cDNA amplicon

text: female

text: embryonic kidney


name: DNAJB1 sensor sequencing with control siRNA and heat shock repl 3

text: Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: DNAJB1 sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: DNAJB1 sensor sequencing (SI Fig 2i)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

characteristic: title


name: DNAJB1 sensor sequencing with siRNA and heat shock repl 3

text: Stanford University

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: DNAJB1 sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: DNAJB1 sensor sequencing (SI Fig 2i)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

characteristic: sex

text: embryonic kidney


name: DNAJB1 trigger sequencing with control siRNA and heat shock repl 1

text: Stanford University

text: live

text: Human

characteristic: age

text: DNAJB1 trigger

characteristic: amplicon target

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: DNAJB1 trigger sequencing (SI Fig 2l)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

characteristic: tissue


name: DNAJB1 trigger sequencing with control siRNA and heat shock repl 2

characteristic: External Id

text: Stanford University

text: live

text: Human

characteristic: SRA accession

text: DNAJB1 trigger

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: DNAJB1 trigger sequencing (SI Fig 2l)

characteristic: description

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney


name: DNAJB1 trigger sequencing with control siRNA and heat shock repl 3

text: Stanford University

characteristic: INSDC center name

text: live

text: Human

text: DNAJB1 trigger

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: DNAJB1 trigger sequencing (SI Fig 2l)

characteristic: isolate

text: Homo sapiens

characteristic: replicate

text: cell culture cDNA amplicon

text: female

text: embryonic kidney


S1 sensor sequencing repl 1

text: Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: S1 sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: S1 sensor sequencing (SI Fig 2g)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

text: 200 ng s70587 + 50 ng ADAR1-p150

characteristic: treatment


name: S1 sensor sequencing with trigger repl 1

text: Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: S1 sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: S1 sensor sequencing (SI Fig 2g)

text: Homo sapiens

characteristic: organism

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

text: 200 ng s70587 + 250 ng BFPmut-3UTR(t70587) + 50 ng ADAR1-p150


S1 sensor sequencing repl 2

text: Stanford University

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: S1 sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: S1 sensor sequencing (SI Fig 2g)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

characteristic: title

text: 200 ng s70587 + 50 ng ADAR1-p150


name: S1 sensor sequencing with trigger repl 2

text: Stanford University

text: live

text: Human

characteristic: age

text: S1 sensor

characteristic: amplicon target

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: S1 sensor sequencing (SI Fig 2g)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

characteristic: sex

text: embryonic kidney


S1 sensor sequencing repl 3

characteristic: External Id

text: Stanford University

text: live

text: Human

characteristic: SRA accession

text: S1 sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: S1 sensor sequencing (SI Fig 2g)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

characteristic: tissue

text: 200 ng s70587 + 50 ng ADAR1-p150


name: S1 sensor sequencing with trigger repl 3

text: Stanford University

characteristic: INSDC center name

text: live

text: Human

text: S1 sensor

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: S1 sensor sequencing (SI Fig 2g)

characteristic: description

characteristic: isolate

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney


name: T1 trigger sequencing with sensor repl 1

text: Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: T1 trigger

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: T1 trigger sequencing (SI Fig 2j)

text: Homo sapiens

characteristic: replicate

text: cell culture cDNA amplicon

text: female

text: embryonic kidney


name: T1 trigger sequencing without sensor repl 1

text: Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: T1 trigger

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: T1 trigger sequencing (SI Fig 2j)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

text: 250 ng BFPmut-3UTR(t70587) + 50 ng ADAR1-p150

characteristic: treatment


name: T1 trigger sequencing with sensor repl 2

text: Stanford University

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: T1 trigger

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: T1 trigger sequencing (SI Fig 2j)

text: Homo sapiens

characteristic: organism

text: cell culture cDNA amplicon

text: female

text: embryonic kidney


name: T1 trigger sequencing without sensor repl 2

text: Stanford University

text: live

text: Human

characteristic: age

text: T1 trigger

characteristic: amplicon target

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: T1 trigger sequencing (SI Fig 2j)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

characteristic: title


name: T1 trigger sequencing with sensor repl 3

characteristic: External Id

text: Stanford University

text: live

text: Human

characteristic: SRA accession

text: T1 trigger

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: T1 trigger sequencing (SI Fig 2j)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

characteristic: sex

text: embryonic kidney


name: T1 trigger sequencing without sensor repl 3

text: Stanford University

characteristic: INSDC center name

text: live

text: Human

text: T1 trigger

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: T1 trigger sequencing (SI Fig 2j)

characteristic: description

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

characteristic: tissue


name: DNAJB1 trigger sequencing without sensor with heat shock repl 1

text: Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: DNAJB1 trigger

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: DNAJB1 trigger sequencing (SI Fig 2l)

characteristic: isolate

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

text: 450 ng s70587 + 50 ng ADAR1-p150 + VCL siRNA + heat shock


name: DNAJB1 trigger sequencing without sensor with heat shock repl 2

text: Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: DNAJB1 trigger

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: DNAJB1 trigger sequencing (SI Fig 2l)

text: Homo sapiens

characteristic: replicate

text: cell culture cDNA amplicon

text: female

text: embryonic kidney


name: DNAJB1 trigger sequencing without sensor with heat shock repl 3

text: Stanford University

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: DNAJB1 trigger

text: Thermo Fisher #R78007

text: HEK 293 Flp-In Trex

text: DNAJB1 trigger sequencing (SI Fig 2l)

text: Homo sapiens

text: cell culture cDNA amplicon

text: female

text: embryonic kidney

characteristic: treatment


text: Naval Medical University

text: live

text: Metagenome or environmental

text: Mus musculus

characteristic: host

text: feces metagenome

characteristic: organism

characteristic: tmp


characteristic: External Id

text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710173 E

text: Mus musculus

text: CBA/N

characteristic: strain

text: MIMARKS Specimen sample from Mus musculus

characteristic: title


text: Nagoya University

characteristic: INSDC center name

text: live

text: MIMARKS.specimen

characteristic: SRA accession

text: Keywords: GSC:MIxS;MIMARKS:5.0

characteristic: description

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710174 E

text: Mus musculus

text: CBA/N


text: Nagoya University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710175 E

text: Mus musculus

text: CBA/N


text: Nagoya University

characteristic: INSDC secondary accession

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710176 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

characteristic: INSDC status

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710177 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710178 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710179 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710180 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710181 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710182 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710183 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710184 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710185 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710186 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710187 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710188 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710189 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710190 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710191 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710192 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710193 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710194 E

text: Mus musculus

text: CBA/N


text: Nagoya University

text: live

text: MIMARKS.specimen

text: Keywords: GSC:MIxS;MIMARKS:5.0

text: Cecum biome

text: Intestinal contents

text: Japan: Nagoya

text: 35.1550569 N 136.9710195 E

text: Mus musculus

text: CBA/N